Laura Deedigan

418 total citations
8 papers, 291 citations indexed

About

Laura Deedigan is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Laura Deedigan has authored 8 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in Laura Deedigan's work include Cell death mechanisms and regulation (4 papers), Mesenchymal stem cell research (4 papers) and RNA Interference and Gene Delivery (3 papers). Laura Deedigan is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Mesenchymal stem cell research (4 papers) and RNA Interference and Gene Delivery (3 papers). Laura Deedigan collaborates with scholars based in Ireland, Germany and United Kingdom. Laura Deedigan's co-authors include Andrea Mohr, Ralf M. Zwacka, Rui Yu, Stella Maris Albarenque, Timothy O’Brien, Frank Barry, Simone Fulda, Mairéad Reidy, Georgina Shaw and Mark Lyons and has published in prestigious journals such as Cell Death and Differentiation, International Journal of Cancer and Anesthesiology.

In The Last Decade

Laura Deedigan

7 papers receiving 285 citations

Peers

Laura Deedigan

MB

GENET

ONCOL

GENET

IMMUN

Lucia Demková Slovakia

Roman Bohovic Slovakia

Davide Ceresa Italy

C Zischek Germany

Andrea Pastorakova Slovakia

Simone Haas Germany

Andrea G. Manzanera United States

Shahrokh Abdolahi Iran

Susann Rahmig Germany

Xia Xu China

Lucia Demková Slovakia

Laura Deedigan

185 ×1.1

MB

55 ×0.5

GENET

161 ×1.9

ONCOL

36 ×0.6

GENET

42 ×0.8

IMMUN

Citations per year, relative to Laura Deedigan Laura Deedigan (= 1×) peers Lucia Demková

Countries citing papers authored by Laura Deedigan

Since Specialization

Citations

This map shows the geographic impact of Laura Deedigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Deedigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Deedigan more than expected).

Fields of papers citing papers by Laura Deedigan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Deedigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Deedigan. The network helps show where Laura Deedigan may publish in the future.

Co-authorship network of co-authors of Laura Deedigan

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Deedigan. A scholar is included among the top collaborators of Laura Deedigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Deedigan. Laura Deedigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Cormican, Sarah, Shirley Hanley, Md Nahidul Islam, et al.. (2025). Initial or continuous coculture with umbilical cord-derived mesenchymal stromal cells facilitates in vitro expansion of human regulatory T-cell subpopulations. Stem Cells Translational Medicine. 14(6).

2.

Watson, Luke, Laura Deedigan, Róisín M. Dwyer, et al.. (2020). Targeting stromal cell Syndecan‐2 reduces breast tumour growth, metastasis and limits immune evasion. International Journal of Cancer. 148(5). 1245–1259. 22 indexed citations

3.

Masterson, Claire, James Devaney, Shahd Horie, et al.. (2018). Syndecan-2–positive, Bone Marrow–derived Human Mesenchymal Stromal Cells Attenuate Bacterial-induced Acute Lung Injury and Enhance Resolution of Ventilator-induced Lung Injury in Rats. Anesthesiology. 129(3). 502–516. 41 indexed citations

4.

Mohr, Andrea, et al.. (2017). Caspase-10: a molecular switch from cell-autonomous apoptosis to communal cell death in response to chemotherapeutic drug treatment. Cell Death and Differentiation. 25(2). 340–352. 21 indexed citations

5.

Yu, Rui, Laura Deedigan, Stella Maris Albarenque, Andrea Mohr, & Ralf M. Zwacka. (2013). Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects. Cell Death and Disease. 4(2). e503–e503. 36 indexed citations

6.

Yu, Rui, et al.. (2011). IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells. Cancer Letters. 316(2). 168–177. 14 indexed citations

7.

Mohr, Andrea, Stella Maris Albarenque, Laura Deedigan, et al.. (2010). Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells. Stem Cells. 28(11). 2109–2120. 74 indexed citations

8.

Mohr, Andrea, Mark Lyons, Laura Deedigan, et al.. (2008). Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model. Journal of Cellular and Molecular Medicine. 12(6b). 2628–2643. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact